22 matches.
New State Legislation Increases Oversight of Health Care Transactions-
New HIPAA Final Rule: Key Changes to Reproductive Health Care Privacy
The DEA Is Knocking at Your Door . . . Are You Prepared?-
The Future of Laboratory Testing Just Got a Little Clearer: FDA's Final Rule on LDTs
-
Down Goes Chevron: A 40-Year Precedent Overturned by the Supreme Court
-
If Cannabis Is Reclassified, What Will Happen to the Marketplace?
Litigating Nutrition: Class Action Battles Over Dietary Supplements-
FDA Releases Laboratory-Developed Tests Final Rule
-
Braidwood v. Becerra: Challenging the Affordable Care Act’s Preventive Services Coverage Provision
-
Game-Changing IRA: Revolutionizing Prescription Drug Pricing and Medicare Benefits
-
Direct Access Laboratory Testing: Future FDA Proposed Regulations on LDTs
-
Inflation Reduction Act’s Drug Price Negotiation Provisions – What Now?
-
Post-Dobbs: One Year Later
-
The Legal Battle Over Mifepristone
-
Direct Access Laboratory Testing: Physician Orders and Specimen Collection
-
Legal and Regulatory Landscape for Psychedelics as Therapies
-
Direct Access Laboratory Testing: Reimbursement & Compliance
-
Direct Access Laboratory Testing: Navigating the Regulatory Landscape
-
Unpacking FDA's Final Clinical Decision Support Guidance
-
Post-Dobbs: Considerations for Clinical Trials and Research
-
Post-Dobbs: Access to Reproductive Health Care and Abortion-Inducing Drugs
-
Impact of COVID-19 on Pharmacist Scope of Practice: Before and After the PREP Act
